Research Program Evaluation Training About Us

Publications: HIV & AIDS

  • Bennett, M., Strachan, E., &Uldall, K. (2010). Development and initial validation of a brief screener for focused HIV prevention efforts. HIV Medicine, 11, 318–325.
  • Bennett, M., Strachan, E., & Uldall, K. (2009). Examining predictors of HIV transmission risk behaviors reveals a potentially useful brief screener for focused prevention efforts. Journal of HIV Medicine.
  • Bennett, W. R. M., Joesch, J. M., Mazur, M., & Roy-Byrne, P. (2009). Characteristics of HIV positive patients treated in a psychiatric emergency department. Psychiatric Services, 60(3), 398-401.
  • Bennett, W.R., Joesch, J.M., Mazur, M., & Roy-Byrne, P. (2009). Characteristics of HIV-positive patients treated in a psychiatric emergency department. Psychiatry Services, 60(3), 398-401.
  • Crane, H.M., Grunfeld, C., Harrington, R.D., Uldall, K.K., Ciechanowski, P.S., Kitahata, M.M. (2008). Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy. HIV Medicine, 9(9), 780-786.
  • Strachan, E., Bennett, M., Russo, J., & Roy-Byrne, P. (2007). Disclosure of HIV status and sexual orientation independently predicts increased CD4 counts over time for psychiatric patients. Psychosomatic Medicine, 69(1), 74-80.
  • Elliot, A.J., Russo, J., Bergam, K., Uldall, K.K., Claypoole, K., & Roy-Byrne, P.P. (1999). Antidepressant efficacy in HIV+ outpatients with major depression: an open trial of Nefazodone. Journal of Clinical Psychiatry, 60, 226-231.
  • Elliot, A.J., Uldall, K.K., Bergam, K., Russo, J., Claypoole, K., & Roy-Byrne, P.P. (1998). Randomized, placebo-controlled trial of Paroxetine vs Imipramine in depressed HIV positive outpatients. American Journal of Psychiatry, 155, 367-372.

  
);